Related Experiment Video
Updated: May 21, 2026
Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
Management of microinvasive cervical cancer: a British Society for Colposcopy and Cervical Pathology audit
Mary Cairns1, John Tidy, Margaret E Cruickshank
1Department of Gynaecological Oncology, Aberdeen Royal Infirmary, Scotland, United Kingdom. marycairns@nhs.net
Unlabelled:
The incidence of microinvasive cervical cancers seems to be increasing as a result of screening. However, there is little national or international guidance on best management or follow-up of women treated with conservation of the cervix.
Objective:
The study aimed to assess the current management and follow-up of women with stage IA cervical cancer, according to the International Federation of Gynecology and Obstetrics, within the United Kingdom.
Design/Setting:
This study is a multicenter national audit of a clinical practice in the United Kingdom.
Materials And Methods:
A structured questionnaire was sent and returned electronically to all lead colposcopists in the United Kingdom on the management and follow-up of women with stage IA cervical cancer according to the International Federation of Gynecology and Obstetrics. The study was approved by the British Society for Colposcopy and Cervical Pathology.
Results:
Of the 210 lead colposcopists, 110 (52%) responded. All reported that women with stage IA cervical cancer are discussed at a gynecologic multidisciplinary team meeting. Women who managed conservatively with their cervix in situ are followed up for at least 5 years. There is a wide variation in clinical management of cases with lymphovascular space involvement (LVSI) and depth of invasion greater than 3 mm (stage IA2).
Conclusions:
The pattern and practice of follow-up for stage IA cervical cancer is highly variable. The development of national guidance should be considered.
